<- Go home

Added to YB: 2021-11-12

Pitch date: 2021-11-12

RXST [bullish]

RxSight, Inc.

+1.99%

current return

Author Info

No bio for this author

Company Info

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.

Market Cap

$400.1M

Pitch Price

$12.29

Price Target

N/A

Dividend

N/A

EV/EBITDA

-4.60

P/E

-11.07

EV/Sales

1.30

Sector

Health Care Equipment and Supplies

Category

N/A

Show full summary:
RXSIGHT INC RXST

A summary for this pitch has not been created yet.

Read full article (0 min)